Driven by a moral commitment to foster positive social change, South African companies are evolving their Corporate Social Investment (CSI) efforts. The majority of their R11.8-billion corporate social investment (CSI) in 2023 was directed toward supporting non-profit organisations (Claire. 2024) To maximise the benefits of CSI to the businesses and the beneficiaries, QC4U helps companies to design strategic CSI projects, execute and monitor their impact. The firm ensures that the CSI investments benefit the deserving beneficiaries (communities), and also employees, and their families while supporting the company’s cost containment efforts- a Win Win Agenda.
We provide expert guidance and technical support to private companies and businesses in designing high-quality HIV and non-communicable disease (NCD) programmes that are responsive, evidence-driven, and sustainable. The service is anchored in supporting Corporate Social Investment (CSI) objectives and employee wellness standards, while promoting positive, equitable, and sustained health outcomes for private health care users. We work closely with clients to ensure alignment between business priorities, workforce wellbeing, and broader health system goals.
We offer expert guidance and support in designing high-quality HIV and non-communicable disease (NCD) programs for private companies and businesses. This program informs continuous evidence-based learning that is purposefully used to adapt program and policy decision making. It is founded on a desire to support the company's CSI and employee wellness standards and policies, as well as positive and sustained health outcomes for private health care users.
Our expert teams work hand in hand with providers, ensuring health initiatives are responsive and impactful while fostering long-term sustainability aligned with the funders/users needs